Pedro Castro Rebollo

Associate Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pedro Castro Rebollo is an Associate Professor at Universitat de Barcelona, Spain. His research focuses on critical illness, particularly in areas such as immunosuppression, pharmacokinetic modeling for antibiotics, and the management of cytomegalovirus infections in immunocompromised patients. He has also conducted studies on clinical debriefing methods and strategies for managing thrombocytopenia in adult ICU patients.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (16)

Arturo Huerta

Head

SPAIN

Pedro Castro Rebollo

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Advocating for the recognition of underlying immunosuppression in critical illness

External validation of population pharmacokinetic models for meropenem in critically ill adult patients

What intensivists need to know about cytomegalovirus infection in immunocompromised ICU patients

Implementation of the TALK© clinical self-debriefing tool in operating theatres: a single-centre interventional study

Platelet transfusions in adult thrombocytopenic ICU patients: Protocol for a sub‐study of the PLOT‐ICU cohort

Correction: Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU)

Platelet transfusions in adult ICU patients with thrombocytopenia

Evaluation of TALK© training for interprofessional clinical debriefing in Latin America

Brain microbleeds resulting from presumed extensive fat emboli in a patient with bone marrow necrosis following a sickle cell disease vaso-occlusive crisis

Platelet transfusions in adult thrombocytopenic ICU patients: Protocol for a sub-study of the PLOT-ICU cohort

Efficacy of Corticosteroids and Intravenous Immunoglobulins in a Patient with Toxic Epidermal Necrolysis Secondary to Sulfadoxine: A Case Report and Literature Review

One-year mortality after ICU admission due to COVID-19 infection

Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study

Device for Negative Pressure Wound Therapy in Low-Resource Regions: Open-Source Description and Bench Test Evaluation

Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality.

Minimally Invasive Tissue Sampling Findings in 12 Patients With Coronavirus Disease 2019

Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients.

Factors associated with the clinical outcome of patients with relapsed/refractory CD19<sup>+</sup> acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.

Collaborators (16)

Arturo Huerta

Manel Juan

Lene Russell

Raquel Almansa

David Ellinghaus

Inmaculada Ribera Cortada

Manuel Castella

Clara Vigneron

Cristina Diaz-Navarro

Pedro V. Castro-Martinez

Anders Perner

Felipe Rodríguez de Castro

Rafael Fernandez

Christine Lodberg Hvas

JESUS CABALLERO

Dolors Soy Muner

Make your next move.